Biologic drugs are life-saving drugs that effectively treat serious illnesses including cancer and autoimmune diseases. However, dosing is usually one-dose-fits-all and the costs are becoming unsustainable. As a result, patients are not getting the most from their treatment. Abreos Biosciences is poised to have a major impact on the delivery of biologic drugs by offering precision dosing tools that will maximize the value of the drugs and expand access of these powerful medications to patients.